Design, Synthesis and Biological Evaluation of Benzohydrazide Derivatives Containing Dihydropyrazoles as Potential EGFR Kinase Inhibitors. 2016

Hai-Chao Wang, and Xiao-Qiang Yan, and Tian-Long Yan, and Hong-Xia Li, and Zhong-Chang Wang, and Hai-Liang Zhu
College of Biology and Food Engineering, Suzhou University, Suzhou 234000, China. wanghc0823@163.com.

A series of novel benzohydrazide derivatives containing dihydropyrazoles have been synthesized as potential epidermal growth factor receptor (EGFR) kinase inhibitors and their biological activities as potential antiproliferative agents have been evaluated. Among these compounds, compound H20 exhibited the most potent antiproliferative activity against four cancer cell line variants (A549, MCF-7, HeLa, HepG2) with IC50 values of 0.46, 0.29, 0.15 and 0.21 μM respectively, which showed the most potent EGFR inhibition activities (IC50 = 0.08 μM for EGFR). Molecular modeling simulation studies were performed in order to predict the biological activity and activity relationship (SAR) of these benzohydrazide derivatives. These results suggested that compound H20 may be a promising anticancer agent.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072283 A549 Cells An immortalized cell line derived from human ADENOCARCINOMA, ALVEOLAR basal epithelial cells isolated from the lungs of a male patient in 1972. The cell line is positive for KERATIN, can synthesize LECITHIN, and contains high levels of POLYUNSATURATED FATTY ACIDS in its PLASMA MEMBRANE. It is used as a model for PULMONARY ALVEOLI function and virus infections, as a TRANSFECTION host, and for PRECLINICAL DRUG EVALUATION. A549 Cell Line,A549 Cell,A549 Cell Lines,Cell Line, A549,Cell Lines, A549,Cell, A549,Cells, A549
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D047428 Protein Kinase Inhibitors Agents that inhibit PROTEIN KINASES. Protein Kinase Inhibitor,Inhibitor, Protein Kinase,Inhibitors, Protein Kinase,Kinase Inhibitor, Protein,Kinase Inhibitors, Protein
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular

Related Publications

Hai-Chao Wang, and Xiao-Qiang Yan, and Tian-Long Yan, and Hong-Xia Li, and Zhong-Chang Wang, and Hai-Liang Zhu
January 2010, Bioorganic & medicinal chemistry,
Hai-Chao Wang, and Xiao-Qiang Yan, and Tian-Long Yan, and Hong-Xia Li, and Zhong-Chang Wang, and Hai-Liang Zhu
January 2016, Bioorganic & medicinal chemistry letters,
Hai-Chao Wang, and Xiao-Qiang Yan, and Tian-Long Yan, and Hong-Xia Li, and Zhong-Chang Wang, and Hai-Liang Zhu
March 2012, Bioorganic & medicinal chemistry,
Hai-Chao Wang, and Xiao-Qiang Yan, and Tian-Long Yan, and Hong-Xia Li, and Zhong-Chang Wang, and Hai-Liang Zhu
August 2022, European journal of medicinal chemistry,
Hai-Chao Wang, and Xiao-Qiang Yan, and Tian-Long Yan, and Hong-Xia Li, and Zhong-Chang Wang, and Hai-Liang Zhu
April 2021, European journal of medicinal chemistry,
Hai-Chao Wang, and Xiao-Qiang Yan, and Tian-Long Yan, and Hong-Xia Li, and Zhong-Chang Wang, and Hai-Liang Zhu
April 2017, European journal of medicinal chemistry,
Hai-Chao Wang, and Xiao-Qiang Yan, and Tian-Long Yan, and Hong-Xia Li, and Zhong-Chang Wang, and Hai-Liang Zhu
February 2024, Bioorganic & medicinal chemistry letters,
Hai-Chao Wang, and Xiao-Qiang Yan, and Tian-Long Yan, and Hong-Xia Li, and Zhong-Chang Wang, and Hai-Liang Zhu
January 2023, Pharmaceuticals (Basel, Switzerland),
Hai-Chao Wang, and Xiao-Qiang Yan, and Tian-Long Yan, and Hong-Xia Li, and Zhong-Chang Wang, and Hai-Liang Zhu
January 2015, Anti-cancer agents in medicinal chemistry,
Hai-Chao Wang, and Xiao-Qiang Yan, and Tian-Long Yan, and Hong-Xia Li, and Zhong-Chang Wang, and Hai-Liang Zhu
August 2018, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!